Journals / Retina-Vitreus / 2004 / Cilt: 12 - Sayı: 2

The effect of the panretinal laser photocoagulation therapy on the driving licence eye exams of the diabetic patients

Diyabetik hastalarda panretinal laser fotokoagulasyon tedavisinin sürücü ehliyet göz muayenesine etkisi

Pages
87–91
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These patients should be advised not to drive during the first month after the end of their PRP treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To determine to what extent the panretinal laser photocoagulation(PRP) therapy applied in diabetic patients affects the legal eye criteria necessary for drivers.
📊
Key Findings & Data:The monoocular central 30- 2 and binocular Esterman perimetric tests using Model 750 Humphrey Visual Field Analyser II were performed before and 1 and 3 months after PRP, respectively.
💡
Conclusion & Impact:These patients should be advised not to drive during the first month after the end of their PRP treatment.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Diabetes mellitus · Görme alanları · Otomobil kullanma

Abstract

Purpose: To determine to what extent the panretinal laser photocoagulation(PRP) therapy applied in diabetic patients affects the legal eye criteria necessary for drivers. Materials and Methods: Early proliferative Type II Diabetic drivers who have recently been scheduled for PRP procedure are included in the study. Complete ocular examination were performed for each patient. Pre- and post- treatment color vision and streopsis examinations were performed for each eye. The monoocular central 30- 2 and binocular Esterman perimetric tests using Model 750 Humphrey Visual Field Analyser II were performed before and 1 and 3 months after PRP, respectively. Results: A total of 74 eyes of 37 patients, 16 females and 21 males were included in the study. The mean age of the patients was 41,8 ± 2,6 years (range, 36-47 years). Visual field defects which are not legally allowed for driving has been noted in 8 patients (% 24,2) at the first month exam upon examination with Esterman binocular visual field analysis, which all disappeared in the thirdmonth exams. There was a significant decrease in the mean retinal sensitivities of central visual field of the patients at the first post-laser month examination (p<0,05). Conclusion: There has been an improvement in binocular and the monoocular visual fields of the PRP treated diabetic patients, who are under the risk of being revoked of their driving licence, three months after the treatment. These patients should be advised not to drive during the first month after the end of their PRP treatment.

Özet

Amaç: Diyabetikli sürücülerde panretinal laser fotokoagulasyon (PRP) tedavisi sonrası, sürücüler için gerekli yasal göz kriterlerinin ne derece etkilendiğinin değerlendirilmesi. Gereç ve Yöntem: PRP tedavilerine karar verilen erken proliferatif diyabetik retinopatili Tip II diyabet mellitus hastası sürücüler çalışmaya dahil edildiler. Hastaların, kırma kusurları belirlenip, ön ve arka seğment muayeneleri gerçekleştirildi. Lazer tedavisi öncesi ve sonrası kontrollerinde renkli görme ve stereopsis muayeneleri yapıldı. PRP tedavisinden önce ve tedaviden 1 ve 3 ay sonra Model 750 Humphrey Alan Analizörü II kullanılarak santral 30-2 monooküler ve Esterman binoküler görme alanı analizleri gerçekleştirildi. Bulgular: Çalışmada, 16'sı kadın, 21'i erkek 37 hastanın toplam 74 gözü değerlendirmeye alındı. Hastaların ortalama yaşı 41,8 ± 2,6 yıl (min-maks, 36-47 yıl) olarak saptandı. PRP sonrası birinci ayda yapılan Esterman binoküler görme alanı analizlerinde 8 hastada (% 24,2) yasal olarak belirlenen sınırı aşan görme alanı kayıpları tespit edilirken bu durumun üçüncü ayda yapılan analizlerde hastaların tamamında ortadan kalktığı saptandı. Hastaların, laser sonrası 1. ayda yapılan santral görme alanı muayenelerinde, ortalama retina duyarlılıklarında anlamlı olarak azalma izlendi (p<0,05). Sonuç: PRP sonrası görme alanlarında sürücü ehliyetlerini riske sokabilecek binoküler görme alanı değişiklikleri saptanan diyabet hastalarının tedavi sonrası 3.aydan itibaren bu durumlarında düzelme görülmektedir. Bu hastaların tedavi sonrası ilk bir ayda mecbur olmadıkça sürücü olarak trafiğe çıkmamaları uygun görünmektedir.

🔖

Cite This Article

AKAR, Y., APAYDIN, C., ÖZER, H. Ö. (2004). The effect of the panretinal laser photocoagulation therapy on the driving licence eye exams of the diabetic patients. Retina-Vitreus, Cilt: 12 - Sayı: 2, 87–91. https://ajindex.com/articles/307986

References (16)

  1. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 1. Early Treatment of Diabetic Retinopathy Study. Arch Ophthalmol 1985; 103: 1796-1806
  2. Ferris FL: How effective are treatments for diabetic retinopathy. JAMA 1993; 269:1290-1291
  3. Mendivil A, Cuartero V, Mendivil MR: Ocular blood flow velocities in patients with proliferative diabetic retinopathy before and after scatter photocoagulation: A prospective study. Eur J Ophthalmol 1995; 5: 259-264
  4. Pahor D.: Automated static perimetry as a screening method for evaluation of retinal perfusion in diabetic retinopathy. Int Ophthalmol 1997; 2.1: 305-309
  5. Manji H, Plant GT: Epilepsy surgery, visual fields, and driving: A study of the visual field criteria for driving in patients after temporal lobe epilepsy surgery with a comparison of Goldmann and Esterman perimetry. J Neurol. Neurosurg. 2000; 68: 80-82
  6. Johnson CA, Keltner JL: Incidence of visual field loss in 20.000 eyes and its relationship to driving performance. Arch Ophthalmol 1983; 101: 371-375
  7. Heijl A, Lindgren G, Olsson J.: The effect of perimetric experience in normal subjects. Arch Ophthalmol 1989; 107: 81-86
  8. Magarral LE, Brown GL, Augsburger JJ.: Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischaemic central retinql vein obstruction. Ophthalmology 1982; 9: 780-784
  9. Rassam SMB, Patel V, Kohner EM.: The effect of hypertension on retinal vascular autoregulation in diabetes mellitus. Éxp Physiol 1995; 80: 53-68
  10. Henricsson M, Heijl A.: Visual fields at different stages of diabetic retinopathy. Acta Ophthalmol 1994,72: 560-569
  11. Hamada S.: Evaluation of diabetic retinopathy by automated static perimetry. Nippon Ganka Gakkai Zasshi 1989; 93:161-166
  12. Khosla PK, Gupta V, Tewari HK, et al.: Automated perimetric changes following panretinal photocoagulation in diabetic retinopathy. Ophthalmic Surg 1993; 24: 256-261
  13. Apaydın KC, Akar Y, Metinsoy M.: Diabetik hastalarda panretinal fotokoagülasyon tedavisinin farklı santral görme alanı bölgelerine etkisi. Ret-Vit 2003; 16: 3-7
  14. Akar Y, Apaydın KC, Özel A.: Panretinal lazer fotokoagülasyon tedavisinin optik sinir başı topografisine etkisinin belirlenmesi. Ret-Vit 2003; 16: 32-38
  15. McLean İM, Mueller E, Franzco RGB, et al.: Visual field assessment and the Austroads driving standard. Clin Exp Ophthalmol 2002; 30:33
  16. Pathak-Ray, Ray A, Walters R, Hatfield R.: Detection, of vis